EUVIMEDEUVIMED entdecken
Leserbrief

Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”

Shih-Wei Lai

American Journal of Nephrology · 2024

DOI: 10.1159/000533172 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Shih-Wei Lai. Beteiligte Einrichtung: Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hosp…. Hauptthemen laut MEDLINE: Febuxostat, Hyperuricemia. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FebuxostatHyperuricemiaHumansAllopurinolGout SuppressantsRenal Dialysis

Stichwörter der Autor:innen

AllopurinolFebuxostatSurvival

Substanzen

FebuxostatAllopurinolGout Suppressants

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.

Zitieren

APA

Lai, S. W. (2024). Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”. American Journal of Nephrology. https://doi.org/10.1159/000533172

Vancouver

Lai SW. Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”. American Journal of Nephrology. 2024. doi:10.1159/000533172

BibTeX
@article{Lai2024,
  author = {Lai, Shih-Wei},
  title = {Comment on Kang et al.’s “Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis”},
  journal = {American Journal of Nephrology},
  year = {2024},
  doi = {10.1159/000533172}
}
Kostenlos starten →